Evidence map›Paper›PMID 36578035›Full record

ArticleActa neuropathologica communications2022

Proteomics of the dentate gyrus reveals semantic dementia specific molecular pathology.

Merel O Mol, Suzanne S M Miedema, Shamiram Melhem, Ka Wan Li, Frank Koopmans, Harro Seelaar, Kurt Gottmann, Volkmar Lessmann, Netherlands Brain Bank, August B Smit and 2 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Merel O MolDepartment of Neurology and Alzheimer Center Erasmus MC, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands. m.o.mol@erasmusmc.nl.ORCID 0000-0003-2533-2530
Suzanne S M MiedemaDepartment of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Shamiram MelhemDepartment of Neurology and Alzheimer Center Erasmus MC, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
Ka Wan LiDepartment of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Frank KoopmansDepartment of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Harro SeelaarDepartment of Neurology and Alzheimer Center Erasmus MC, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
Kurt GottmannInstitute of Neuro- and Sensory Physiology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Volkmar LessmannInstitute of Physiology, Medical Faculty, Otto-Von-Guericke University, Magdeburg, Germany.
Netherlands Brain BankNetherlands Institute for Neuroscience, Amsterdam, The Netherlands.
August B SmitDepartment of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
John C van SwietenDepartment of Neurology and Alzheimer Center Erasmus MC, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
Jeroen G J van RooijDepartment of Neurology and Alzheimer Center Erasmus MC, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
Erasmus MC · NLAmsterdam Neuroscience · NLHeinrich Heine University Düsseldorf · DENetherlands Institute for Neuroscience · NLOtto-von-Guericke-Universität Magdeburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Semantic dementia (SD) is a clinical subtype of frontotemporal dementia consistent with the neuropathological diagnosis frontotemporal lobar degeneration (FTLD) TDP type C, with characteristic round TDP-43 protein inclusions in the dentate gyrus. Despite this striking clinicopathological concordance, the pathogenic mechanisms are largely unexplained forestalling the development of targeted therapeutics. To address this, we carried out laser capture microdissection of the dentate gyrus of 15 SD patients and 17 non-demented controls, and assessed relative protein abundance changes by label-free quantitative mass spectrometry. To identify SD specific proteins, we compared our results to eight other FTLD and Alzheimer's disease (AD) proteomic datasets of cortical brain tissue, parallel with functional enrichment analyses and protein-protein interactions (PPI). Of the total 5,354 quantified proteins, 151 showed differential abundance in SD patients (adjusted P-value < 0.01). Seventy-nine proteins were considered potentially SD specific as these were not detected, or demonstrated insignificant or opposite change in FTLD/AD. Functional enrichment indicated an overrepresentation of pathways related to the immune response, metabolic processes, and cell-junction assembly. PPI analysis highlighted a cluster of interacting proteins associated with adherens junction and cadherin binding, the cadherin-catenin complex. Multiple proteins in this complex showed significant upregulation in SD, including β-catenin (CTNNB1), γ-catenin (JUP), and N-cadherin (CDH2), which were not observed in other neurodegenerative proteomic studies, and hence may resemble SD specific involvement. A trend of upregulation of all three proteins was observed by immunoblotting of whole hippocampus tissue, albeit only significant for N-cadherin. In summary, we discovered a specific increase of cell adhesion proteins in SD constituting the cadherin-catenin complex at the synaptic membrane, essential for synaptic signaling. Although further investigation and validation are warranted, we anticipate that these findings will help unravel the disease processes underlying SD.

Indexed as

Alzheimer DiseaseFrontotemporal DementiaFrontotemporal Lobar DegenerationCadherinsCateninsDentate GyrusHumansPathology, MolecularProteomicsCadherinsCateninsCadherin-catenin complexFrontotemporal dementiaFrontotemporal lobar degenerationMass spectrometryProteomicsSemantic dementiaTDP-43β-catenin

Identifiers

PMID36578035
PMCPMC9795759
OpenAlexW4312213868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.